Debt-to-equity in % of CAPRICOR THERAPEUTICS, INC. from Q1 2013 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CAPRICOR THERAPEUTICS, INC. quarterly Debt-to-equity history and change rate from Q1 2013 to Q3 2025.
  • CAPRICOR THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 26.5 %, a 73% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 26.5 -71.7 -73% 30 Sep 2025
Q2 2025 23.4 -238 -91.1% 30 Jun 2025
Q1 2025 29.1 -327 -91.8% 31 Mar 2025
Q4 2024 44.1 -514 -92.1% 31 Dec 2024
Q3 2024 98.2 -790 -88.9% 30 Sep 2024
Q2 2024 262 -202 -43.6% 30 Jun 2024
Q1 2024 356 +41.7 +13.3% 31 Mar 2024
Q4 2023 558 +336 +152% 31 Dec 2023
Q3 2023 888 +746 +525% 30 Sep 2023
Q2 2023 464 +378 +439% 30 Jun 2023
Q1 2023 314 +264 +527% 31 Mar 2023
Q4 2022 222 +200 +917% 31 Dec 2022
Q3 2022 142 +122 +622% 30 Sep 2022
Q2 2022 86.1 +65.9 +326% 30 Jun 2022
Q1 2022 50.1 +30.5 +155% 31 Mar 2022
Q4 2021 21.8 -0.61 -2.72% 31 Dec 2021
Q3 2021 19.7 -6.1 -23.7% 30 Sep 2021
Q2 2021 20.2 -16.2 -44.5% 30 Jun 2021
Q1 2021 19.6 -62 -76% 31 Mar 2021
Q4 2020 22.4 -89.2 -79.9% 31 Dec 2020
Q3 2020 25.8 -106 -80.4% 30 Sep 2020
Q2 2020 36.4 -75 -67.3% 30 Jun 2020
Q1 2020 81.6 +3.69 +4.74% 31 Mar 2020
Q4 2019 112 +50.4 +82.4% 31 Dec 2019
Q3 2019 131 +79.8 +154% 30 Sep 2019
Q2 2019 111 -16.5 -12.9% 30 Jun 2019
Q1 2019 77.9 -388 -83.3% 31 Mar 2019
Q4 2018 61.2 +1.05K 31 Dec 2018
Q3 2018 51.7 +437 30 Sep 2018
Q2 2018 128 +631 30 Jun 2018
Q1 2018 466 +1K 31 Mar 2018
Q4 2017 -985 -155 -18.7% 31 Dec 2017
Q3 2017 -385 +710 +64.8% 30 Sep 2017
Q2 2017 -503 +856 +63% 30 Jun 2017
Q1 2017 -538 -2.19K -132% 31 Mar 2017
Q4 2016 -830 -1.41K -243% 31 Dec 2016
Q3 2016 -1.09K -2.11K -207% 30 Sep 2016
Q2 2016 -1.36K -8.25K -120% 30 Jun 2016
Q1 2016 1.66K +2.92K 31 Mar 2016
Q4 2015 582 +1.1K 31 Dec 2015
Q3 2015 1.02K +1.7K 30 Sep 2015
Q2 2015 6.9K +7.58K 30 Jun 2015
Q1 2015 -1.27K -731 -136% 31 Mar 2015
Q4 2014 -516 -256 -98.5% 31 Dec 2014
Q3 2014 -677 -1.01K -305% 30 Sep 2014
Q2 2014 -685 -803 -683% 30 Jun 2014
Q1 2014 -539 -591 -1134% 31 Mar 2014
Q4 2013 -260 31 Dec 2013
Q3 2013 331 30 Sep 2013
Q2 2013 118 30 Jun 2013
Q1 2013 52.1 31 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.